Zhejiang Taimei Medical Technology Co., Ltd. (TAIMEI TECH) filed its Monthly Return for the period ended 31 March 2026, confirming that no changes occurred in either registered or issued share capital during the month.

The company’s registered share capital remained at 563.78 million shares, each with a par value of RMB 1.00. This total comprises 200.59 million H shares listed in Hong Kong and 363.19 million domestic shares, both unchanged from the previous month.

Issued H shares stood at 200.43 million, while 167,400 H shares continued to be held in treasury, leaving total issued H shares at 200.59 million. Domestic issued shares were unchanged at 363.19 million, and the company reported no share repurchases, cancellations, or new issuances across all share classes.

TAIMEI TECH confirmed full compliance with the Main Board’s minimum public-float requirement, maintaining at least 25% public float for its H shares as at 31 March 2026.

Although the board adopted a 2026 H Share Award Scheme on 14 February 2026, no shares were issued or transferred under the scheme during March. The absence of movements in options, warrants, or convertible instruments further underscores the stability of the company’s equity structure for the month.